Wu, S., Xu, H., Xu, L., Zhang, H., Cheng, K., Wang, X., . . . Ge, J. (2025). Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial. Wiley. https://doi.org/10.1111/1753-0407.70152
Chicago Style (17th ed.) CitationWu, Shujing, et al. Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial. Wiley, 2025. https://doi.org/10.1111/1753-0407.70152.
MLA (9th ed.) CitationWu, Shujing, et al. Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial. Wiley, 2025. https://doi.org/10.1111/1753-0407.70152.
Warning: These citations may not always be 100% accurate.